IP31-12: Can active surveillance be safely expanded to intermediate-risk disease?

IP31-12: Can active surveillance be safely expanded to intermediate-risk disease?

Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)

145AB

Abstract

Speakers

MASAHIRO TOIDE

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Sessions

IP31: Prostate Cancer: Localized: Active Surveillance

Saturday, May 16, 2026 9:30 AM to 11:30 AM

Aria Olumi · Janet & William Dewolf Professor of Urology

LARA RODRIGUEZ SANCHEZ · Institut Médico-chirurgical Montsouris

Rafael Sanchez-Salas · McGill University

Log in

See all the content and easy-to-use features by logging in or registering!